Wed, Jul 23, 2014, 10:47 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Pfizer Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fizrwinnr11 fizrwinnr11 Nov 9, 2012 7:34 PM Flag

    Mannkind-MNKD Afrezza Approval Run-Up

    Even if they gain approval, it won't mean much as most insurers WILL NOT REIMBURSE. The precedent was set when insurers wouldn't reimburse for Pfizer's approved product on the grounds that it was strictly a convenience product and they weren't going to pay two or three times the rate for injected insulin for a product that had absolutely no added efficacy.

    On the other side of the pond, the U.K. government insurance plan wouldn't reimburse unless a patient first saw a psychiatrist and was duly certified to be "extremely needle phobic." How many people are about to do that?

    With such a potential tiny market, no big pharma is going to partner with MNKD because the profits just aren't there. And MNKD MUST have a partner since ii simply doesn't have the needed sales force or infrastructure. This stock is strictly one to stay away from unless you enjoy losing your money.

    .

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PFE
30.39-0.10(-0.33%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.